Related references
Note: Only part of the references are listed.The Gβ5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma
D. Fuchs et al.
ONCOGENE (2015)
Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis
S. Josson et al.
ONCOGENE (2015)
Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment
Melissa K. Brunckhorst et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery
Bruce A. Ruggeri et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
Tania Valencia et al.
CANCER CELL (2014)
Remodeling of Channel-Forming ORAI Proteins Determines an Oncogenic Switch in Prostate Cancer
Charlotte Dubois et al.
CANCER CELL (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance
Maja T. Tomicic et al.
CANCER RESEARCH (2014)
MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells
Carla Boccaccio et al.
CANCER RESEARCH (2014)
Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
Paraskevi Mallini et al.
CANCER TREATMENT REVIEWS (2014)
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Ruth Scherz-Shouval et al.
CELL (2014)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario L. Suva et al.
CELL (2014)
Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Armel Herve Nwabo Kamdje et al.
CELLULAR SIGNALLING (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Fibroblasts in myocardial infarction: A role in inflammation and repair
Arti V. Shinde et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Senescent stroma promotes prostate cancer progression: The role of miR-210
Maria Letizia Taddei et al.
MOLECULAR ONCOLOGY (2014)
NF-κB in Cellular Senescence and Cancer Treatment
Hua Jing et al.
MOLECULES AND CELLS (2014)
CELL BIOLOGY The beginning of the end
Judith Campisi
NATURE (2014)
Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia
Monique Dail et al.
NATURE (2014)
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
Andriy Marusyk et al.
NATURE (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Integrin β3 links therapy resistance and cancer stem cell properties
Nagarajan Kannan et al.
NATURE CELL BIOLOGY (2014)
Evil defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
T. Sato et al.
ONCOGENE (2014)
Engineered nanomedicine for myeloma and bone microenvironment targeting
Archana Swami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tumor Microenvironment and Metabolism in Prostate Cancer
Paola Chiarugi et al.
SEMINARS IN ONCOLOGY (2014)
CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
Yumi Kinugasa et al.
STEM CELLS (2014)
Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Daniel Ackerman et al.
TRENDS IN CELL BIOLOGY (2014)
Animal models and therapeutic molecular targets of cancer: utility and limitations
Maria Cekanova et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals
Laura Gatti et al.
ONCOTARGET (2014)
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
Koichi Azuma et al.
ONCOTARGET (2014)
Dependence of cancer cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-free resonant waveguide grating biosensor
Norbert Orgovan et al.
SCIENTIFIC REPORTS (2014)
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Fei Chen et al.
PROTEIN & CELL (2014)
The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia
Xia Sheng et al.
FRONTIERS IN PEDIATRICS (2014)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer
Sofia Torres et al.
CLINICAL CANCER RESEARCH (2013)
Intradermal adipocytes mediate fibroblast recruitment during skin wound healing
Barbara A. Schmidt et al.
DEVELOPMENT (2013)
Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma Through Activation of Epidermal Growth Factor Receptor
Audrey Claperon et al.
HEPATOLOGY (2013)
Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133+ Stem/Progenitor Cells to Battle Prostate Cancer
Dong-Rong Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells
Urszula M. Polanska et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Role of the extracellular matrix in regulating stem cell fate
Fiona M. Watt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity
R. Castoldi et al.
ONCOGENE (2013)
Antibody Therapeutics in Cancer
Mark X. Sliwkowski et al.
SCIENCE (2013)
Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer
Sandro Goruppi et al.
TRENDS IN CELL BIOLOGY (2013)
'Cancer associated fibroblasts' - more than meets the eye
Shalom Madar et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
Osvaldo Pontiggia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Taru Muranen et al.
CANCER CELL (2012)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway
Olaf Hardt et al.
CANCER LETTERS (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Molecular Pathways: Involving Microenvironment Damage Responses in Cancer Therapy Resistance
Yu Sun et al.
CLINICAL CANCER RESEARCH (2012)
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Feiyan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models
Hiroko Oshima et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase-Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells
Ann-Charlotte Johansson et al.
MOLECULAR CANCER RESEARCH (2012)
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+Breast Cancer by Expanding the Cancer Stem Cell Population
Hasan Korkaya et al.
MOLECULAR CELL (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
The tumor microenvironment controls drug sensitivity
Arne Ostman
NATURE MEDICINE (2012)
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun et al.
NATURE MEDICINE (2012)
Challenges Facing JAK Inhibitor Therapy for Myeloproliferative Neoplasms
Ayalew Tefferi
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Kelly L. Mueller et al.
BREAST CANCER RESEARCH (2012)
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Jingqi Chen et al.
CANCER CELL (2011)
Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
Lyndsay V. Rhodes et al.
CANCER RESEARCH (2011)
Chemotherapeutic Resistance: Surviving Stressful Situations
Luke A. Gilbert et al.
CANCER RESEARCH (2011)
Bone Marrow Stroma-Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
Taghi Manshouri et al.
CANCER RESEARCH (2011)
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
Li Lin et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
Mechanisms of integrin activation and trafficking
Coert Margadant et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Immune microenvironments in solid tumors: new targets for therapy
Stephen L. Shiao et al.
GENES & DEVELOPMENT (2011)
Matrix Stiffness Modulates Proliferation, Chemotherapeutic Response, and Dormancy in Hepatocellular Carcinoma Cells
Joerg Schrader et al.
HEPATOLOGY (2011)
Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
Michael F. Emmons et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis-A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
Sharareh Siamakpour-Reihani et al.
PLOS ONE (2011)
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
Douglas W. McMillin et al.
PLOS ONE (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Pipsa Saharinen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
Govardhanan Nagaiah et al.
JOURNAL OF ONCOLOGY (2011)
Neutrophils in the activation and regulation of innate and adaptive immunity
Alberto Mantovani et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Fat tissue, aging, and cellular senescence
Tamara Tchkonia et al.
AGING CELL (2010)
Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: Latest advances towards an integrated approach
Laura Vera-Ramirez et al.
CANCER TREATMENT REVIEWS (2010)
DNA Damage-Mediated Induction of a Chemoresistant Niche
Luke A. Gilbert et al.
CELL (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Hypoxic Tumor Microenvironments Reduce Collagen I Fiber Density
Samata M. Kakkad et al.
NEOPLASIA (2010)
PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
Yongping Crawford et al.
CANCER CELL (2009)
β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
David Lesniak et al.
CANCER RESEARCH (2009)
Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway
Andrew Courtwright et al.
CANCER RESEARCH (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Stromal Matrix Protein Expression Following Preoperative Systemic Therapy in Breast Cancer
Anna-Maria Tokes et al.
CLINICAL CANCER RESEARCH (2009)
Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wei Wang et al.
CLINICAL CANCER RESEARCH (2009)
Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma
Philippe Moreau
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes
Rhonda Hattar et al.
BREAST CANCER RESEARCH (2009)
IL6/slIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice
Francesca Walker et al.
BLOOD (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Extracellular matrix regulation of drug resistance in small-cell lung cancer
P. S. Hodkinson et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions
Stephen Hiscox et al.
ENDOCRINE-RELATED CANCER (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
β1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts
HL Goel et al.
CANCER RESEARCH (2005)
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells
TN Hartmann et al.
ONCOGENE (2005)
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
CA Sherman-Baust et al.
CANCER CELL (2003)
Share Paper
